Company: HURA
Filing Date: 2025-05-23
Form Type: 424B3
Source: 0001193125-25-125499
Chunk: 307

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-05-23
Form: 424B3
Chunk 307
---
 sets forth the name, age and position of each of the nominees at the TuHURA special meeting:

| Name                     |     | Age |     | Position(s)                          |
| James Bianco, M.D.       |     |  68 |     | Chief Executive Officer and Director |
| James Manuso, Ph.D., MBA |     |  76 |     | Director and Chairman of the Board   |
| Alan List, M.D.          |     |  70 |     | Director                             |
| George Ng                |     |  51 |     | Director                             |
| Robert E. Hoffman        |     |  59 |     | Director                             |
| Craig Tendler, M.D       |     |  66 |     | Director                             |

Required Vote The nominees for director who receive the most votes properly cast (also known as a plurality) will be elected. You may either vote “ FOR” the nominees or “ WITHHOLD” your vote from the nominees. Withheld votes and broker non-votes, if any, will have no effect on the Director Election Proposal. Completion of the Mergers is not conditioned upon the election of the director nominees named in the Director Election Proposal. 190

Unless otherwise instructed, it is the intention of the persons named in the accompanying
proxy card to vote shares represented by properly executed proxy cards “FOR” the election of the director nominees named in the Director Election Proposal. However, if the nominees are unable to serve or for good cause will not
serve as a director, the proxies will be voted for the election of such substitute nominees as the TuHURA Board of Directors may designate.

THE TUHURA BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS A VOTE “FOR” THE DIRECTOR NOMINEES NAMED IN THE DIRECTOR ELECTION PROPOSAL.

191

TUHURA PROPOSAL 4: ADVISORY VOTE ON EXECUTIVE COMPENSATION

In accordance with Section 14A of the Securities Exchange Act, and the Dodd-Frank Act, TuHURA is asking its stockholders to vote, on
a non-binding advisory basis, on the approval of the compensation of TuHURA’s named executive officers as disclosed in this joint proxy statement/prospectus.

The TuHURA Board of Directors and TuHURA’s compensation committee believes that TuHURA’s compensation policies and practices are
effective in achieving our goals of motivating and retaining TuHURA’s executives by motivating